Weight loss medications like Ozempic and Wegovy have become increasingly popular over the past few years. For those who are ...

Telehealth platform Hims & Hers said on Friday it will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S ...

WeightWatchers has turned its back on its traditional business model and has caved to peddling the weight loss drugs that ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Dr. Arie Szatkowski explains new obesity medications and their benefits, risks, and who they’re really for—thanks to Stern ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

The medication initially helped get his type 2 diabetes into remission, and enjoy active social excursions that he couldn't ...

Misleading ads on social media are promoting products that doctors say are not effective but mimic the names of more ...

Hims & Hers Health Inc. is cutting more than 4% of its workforce as it pivots away from selling cheap copycat versions of ...

In a breakthrough study from Voy, in collaboration with Imperial College London, researchers have confirmed that combining ...